Atlas Trials

Evaluating the Effectiveness and Tolerance of Baricitinib in the Treatment of Acute Alopecia Areata With Active Hair Shedding: A Prospective Open-Label Study

Clinical trial NCT06797310 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06797310
Sponsor
National Taiwan University Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Alopecia Areata
Start date
2025-01-23
Primary completion
2025-12-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.